Effectiveness of Jeryl Lynn-containing vaccine in Spanish children.
We evaluated the effectiveness of the Jeryl Lynn strain vaccine in a large outbreak of mumps in Navarre, Spain, 2006-2008. Each of the 241 cases of mumps occurring in children over 15 months of age born between 1998 and 2005 was compared with 5 controls individually matched by sex, birth date, district of residence and paediatrician. Vaccination history was obtained blindly from clinical records. Conditional logistic regression was used to obtain the matched odds ratios (ORs), and effectiveness was calculated as 1-OR. Some 70% of cases had received one dose of measles-mumps-rubella vaccine, and 24% had received two doses. Overall vaccine effectiveness was 72% (95% CI, 39-87%). Two doses were more effective (83%; 54-94%) than a single dose (66%; 25-85%). Among vaccinated children, risk was higher in those who had received the first dose after 36 months of age (OR=3.1; 1.2-8.4) and those who had received the second dose 3 or more years before study enrolment (OR=10.2; 1.5-70.7). Early waning of immunity in children after the second dose may contribute to reduced vaccine effectiveness for mumps prevention.
Castilla
Jesús
J
Instituto de Salud Pública de Navarra, Pamplona, Spain. jcastilc@navarra.es
García Cenoz
Manuel
M
Arriazu
Maite
M
Fernández-Alonso
Mirian
M
Martínez-Artola
Víctor
V
Etxeberria
Jaione
J
Irisarri
Fátima
F
Barricarte
Aurelio
A
D000367:Age Factors; D000914:Antibodies, Viral / Q000097:blood; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D018563:Disease Notification; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D017589:Immunization Programs; D007117:Immunization, Secondary; D007223:Infant; D016015:Logistic Models; D008297:Male; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage*; D009107:Mumps / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control*; D016017:Odds Ratio; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology; D014611:Vaccination
D000914:Antibodies, Viral; D022542:Measles-Mumps-Rubella Vaccine